Research output per year
Research output per year
Search results
-
2024
Ivosidenib for treating advanced cholangiocarcinoma with an IDH1 R132 mutation after 1 or more systemic treatments
Imamura, M., Getaneh, A., Cooper, D., Cruickshank, M., Manson, P., Shaukat, A. A., Brazzelli, M. & Scotland, G., 31 Jan 2024, National Institute for Health and Care Excellence (NICE). 20 p.Research output: Book/Report › Commissioned Report